The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zyryanov S.K.

Patrice Lumumba Peoples’ Friendship University of Russia;
City Clinical Hospital No. 24

Vozzhaev A.V.

Patrice Lumumba Peoples’ Friendship University of Russia

Modern approaches to rational combination pharmacotherapy of allergic rhinitis

Authors:

Zyryanov S.K., Vozzhaev A.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2024;89(4): 68‑77

DOI: 10.17116/otorino20248904168

Read: 2191 times

Download PDF (RU)
Contact the author
Table of contents

MODERN APPROACHES TO RATIONAL COMBINATION PHARMACOTHERAPY OF ALLERGIC RHINITIS
MODERN APPROACHES TO RATIONAL COMBINATION PHARMACOTHERAPY OF ALLERGIC RHINITIS

To cite this article:

Zyryanov SK, Vozzhaev AV. Modern approaches to rational combination pharmacotherapy of allergic rhinitis. Russian Bulletin of Otorhinolaryngology. 2024;89(4):68‑77. (In Russ.)
https://doi.org/10.17116/otorino20248904168

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Differentiated approach to the choice of agents for pathogenetic drug therapy in patients with alle­rgic rhinitis. Russian Rhinology. 2025;(1):18-26
Effi­cacy and safety of mome­tasone and olopatadine combination for nasal use in patients with alle­rgic rhinitis caused by sensitization to epidermal alle­rgens in continuous expo­sure. Russian Rhinology. 2025;(1):48-56
Influence of age and sex on values of SNOT-22 sino­nasal test domains in children and adolescents with bronchial asthma. Russian Rhinology. 2025;(3):197-204
Abstract:

Allergic rhinitis (AR) can significantly reduce the quality of life of patients leading to increased fatigue, mood changes, cognitive impairment, and depression. In clinical practice, insufficient effectiveness of initial AR monotherapy is often noted, and a significant proportion of patients referring for medical care have moderate-severe AR. In this regard, the issues of optimization of combined pharmacological treatment of AR are becoming more and more urgent. This paper provides analysis of the opportunities of combined pharmacotherapy within the framework of current management strategy of AR. Based on the results of some studies and known pharmacological properties of medications it is being discussed the advantages of combined use of intranasal corticosteroids and leukotriene receptor antagonists, in particular mometasone furoate and montelukast, in the therapy of AR, including such comorbidities as bronchial asthma, chronic polyposis rhinosinusitis and pharyngeal tonsil hyperplasia. Some aspects of combination therapy with montelukast and second-generation systemic antihistamines as an alternative approach in case of inability to take intranasal corticosteroids, including the reasonability of using a fixed combination of montelukast and levocetirizine, are analyzed from the perspective of rational pharmacotherapy. The problem of interchangeability of brand-name and generic drugs for the treatment of AR is discussed, considering the almost complete absence of studies of their therapeutic equivalence.

Keywords:

allergic rhinitis
leukotriene receptor antagonists
antihistamines
intranasal corticosteroids
combined pharmacotherapy
fixed combination

Authors:

Zyryanov S.K.

Patrice Lumumba Peoples’ Friendship University of Russia;
City Clinical Hospital No. 24

Vozzhaev A.V.

Patrice Lumumba Peoples’ Friendship University of Russia

Received:

01.06.2024

Accepted:

03.06.2024

Close metadata

References:

  1. Klinicheskie rekomendatsii. Allergicheskij rinit. 2021. Odobreno Nauchno-prakticheskim sovetom Ministerstva zdravookhraneniya Rossijskoj Federatsii. (In Russ.). Accessed June 27, 2024. https://cr.minzdrav.gov.ru/schema/261_1
  2. Astafieva NG, Baranov AA, Vishneva EA, Daihes NA, Zhestkov AV, Ilina NI, Karneeva OV, Karpova EP, Kim IA, Kryukov AI, Kurbacheva OM, Meshkova RY, Namazova-Baranova LS, Nenasheva NM, Novik GA, Nosulya EV, Pavlova KS, Pampura AN, Svistushkin VM, Selimzyanova LR, Khaitov MR, Khaitov RM. Allergic rhinitis. Rossijskij allergologicheskij zhurnal. 2022;19(1):100-141. (In Russ.). https://doi.org/10.36691/RJA1524
  3. Cingi C, Gevaert P, Mösges R, Rondon C, Hox V, Rudenko M, Muluk NB, Scadding G, Manole F, Hupin C, Fokkens WJ, Akdis C, Bachert C, Demoly P, Mullol J, Muraro A, Papadopoulos N, Pawankar R, Rombaux P, Toskala E, Kalogjera L, Prokopakis E, Hellings PW, Bousquet J. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clinical and Translational Allergy. 2017;7:17.  https://doi.org/10.1186/s13601-017-0153-z
  4. Karneeva OV, Novik GA, Gurov AV. Modern approaches to the treatment of acute and chronic rhinitis. VIII St. Petersburg International Forum of Otorhinolaryngologists of Russia. MSD Satellite Symposium. Effective pharmacotherapy. Pul’monologiya i otorinolaringologiya. 2019;15(30). (In Russ.).
  5. Iordache A, Balica NC, Horhat ID, Morar R, Tischer AA, Milcu AI, Salavat MC, Borugă VM. A Review Regarding the Connections between Allergic Rhinitis and Asthma — Epidemiology, Diagnosis and Treatment. Current Health Sciences Journal. 2023;49(1):5-18.  https://doi.org/10.12865/CHSJ.49.01.5
  6. Xiang R, Zhang QP, Zhang W, Kong YG, Tan L, Chen SM, Deng YQ, Tao ZZ, Xu Y. Different effects of allergic rhinitis on nasal mucosa remodeling in chronic rhinosinusitis with and without nasal polyps. European Archives of Oto-Rhino-Laryngology. 2019;276(1):115-130.  https://doi.org/10.1007/s00405-018-5195-x
  7. Ryazantsev SV, Pavlova SS. Difficult nasal breathing in the ENT-practice: how to help? Rossijskaya otorinolaringologiya. 2020;2(19): 107-115. (In Russ.). https://doi.org/10.18692/1810-4800-2020-2-107-115
  8. Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, Muraro A, Postma MJ, Kocks JWH, van Boven JFM. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert Review of Pharmacoeconomics and Outcomes Research. 2020;20(5):437-453.  DierickBJH,vanderMolenT,Flokstra-deBlokBMJ,MuraroA,PostmaMJ,KocksJWH,vanBovenJFM.
  9. Nur Husna SM, Tan HTT, Md Shukri N, Mohd Ashari NS, Wong KK. Allergic Rhinitis: A Clinical and Pathophysiological Overview. Frontiers in Medicine. 2022;9:874114. https://doi.org/10.3389/fmed.2022.874114
  10. Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. Allergy. 2021;76(11):3383-3389. https://doi.org/10.1111/all.15044
  11. Meng Y, Wang C, Zhang L. Advances and novel developments in allergic rhinitis. Allergy. 2020;75(12):3069-3076. https://doi.org/10.1111/all.14586
  12. Sharma K, Akre S, Chakole S, Wanjari MB. Allergic Rhinitis and Treatment Modalities: A Review of Literature. Cureus. 2022;14(8): e28501. https://doi.org/10.7759/cureus.28501
  13. Skorokhodkina OV, Volkova DA, Luntsov AV, Khakimova MR, Valeeva AR. Selecting an optimal pharmacotherapy for allergic rhinitis from the standpoint of guidelines and observation in real-life clinical practice. Meditsinskij sovet. 2023;7:80-88. (In Russ.).
  14. Van Bulck P, Cools L, Soumya MS, Nyembue DT, Kabobo P, Zhang L, Scadding GK, Toskala E, Fokkens WJ, Steelant B, Hellings PW. A multicenter real-life study on the multiple reasons for uncontrolled allergic rhinitis. International Forum of Allergy and Rhinology. 2021;11(10):1452-1460. https://doi.org/10.1002/alr.22808
  15. Shilenkova VV, Nenasheva NM. Allergic rhinitis: what is the patient’s choice of drug based on? Russian study’s results. Vestnik otorinolaringologii. 2021;2(86):54-61. (In Russ.). https://doi.org/10.17116/otorino20218602154
  16. Nosulya EV, Kim IA, Kunelskaya VYa, Luchsheva YuV. Advanced Therapy of Allergic Rhinitis: Possibilities, Limitations and Prospects. Rossijskaya rinologiya. 2023;1(31):54-59. (In Russ.).
  17. Gani F, Lombardi C, Barrocu L, Landi M, Ridolo E, Bugiani M, Rolla G, Senna G, Passalacqua G. The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study. Clinical and Molecular Allergy. 2018;16(1):4.  https://doi.org/10.1186/s12948-018-0082-y
  18. Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J. Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care. International Archives of Allergy and Immunology. 2012;160(4):393-400.  https://doi.org/10.1159/000342991
  19. Ryazantsev SV, Budkovaya MA, Rebrova SA. Allergic rhinitis: a comprehensive view of the problem. Meditsinskij sovet. 2023;19: 106-112. (In Russ.). https://doi.org/10.21518/ms2023-397
  20. Nenasheva NM, Shilenkova VV. Control of allergic rhinitis symptoms in adults in the Russian Federation: online survey results. RMZh. Meditsinskoe obozrenie. 2021;5(1):25-31. (In Russ.). https://doi.org/10.32364/2587-6821-2021-5-8-1-8
  21. Caimmi D, Baiz N, Sanyal S, Banerjee S, Demoly P, Annesi-Maesano I. Discriminating severe seasonal allergic rhinitis. Results from a large nation-wide database. PLoS One. 2018;13(11):e0207290. https://doi.org/10.1371/journal.pone.0207290
  22. Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, Klimek L, Pfaar O, Wallace D, Ansotegui I, Agache I, Bedbrook A, Bergmann KC, Bewick M, Bonniaud P, Bosnic-Anticevich S, Bossé I, Bouchard J, Boulet LP, Brozek J, Brusselle G, Calderon MA, Canonica WG, Caraballo L, Cardona V, Casale T, Cecchi L, Chu DK, Costa EM, Cruz AA, Czarlewski W, D’Amato G, Devillier P, Dykewicz M, Ebisawa M, Fauquert JL, Fokkens WJ, Fonseca JA, Fontaine JF, Gemicioglu B, van Wijk RG, Haahtela T, Halken S, Ierodiakonou D, Iinuma T, Ivancevich JC, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kleine Tebbe J, Kowalski ML, Kuna P, Kvedariene V, La Grutta S, Larenas-Linnemann D, Lau S, Laune D, Le L, Lieberman P, Lodrup Carlsen KC, Lourenço O, Marien G, Carreiro-Martins P, Melén E, Menditto E, Neffen H, Mercier G, Mosgues R, Mullol J, Muraro A, Namazova L, Novellino E, O’Hehir R, Okamoto Y, Ohta K, Park HS, Panzner P, Passalacqua G, Pham-Thi N, Price D, Roberts G, Roche N, Rolland C, Rosario N, Ryan D, Samolinski B, Sanchez-Borges M, Scadding GK, Shamji MH, Sheikh A, Bom AT, Toppila-Salmi S, Tsiligianni I, Valentin-Rostan M, Valiulis A, Valovirta E, Ventura MT, Walker S, Waserman S, Yorgancioglu A, Zuberbier T; Allergic Rhinitis and Its Impact on Asthma Working Group. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. Journal of Allergy and Clinical Immunology. 2020;145(1):70-80.e3.  https://doi.org/10.1016/j.jaci.2019.06.049
  23. Wu EL, Harris WC, Babcock CM, Alexander BH, Riley CA, McCoul ED. Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis. Otolaryngology — Head and Neck Surgery. 2019;161(1):18-27.  https://doi.org/10.1177/0194599819832277
  24. Donaldson AM, Choby G, Kim DH, Marks LA, Lal D. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults. Otolaryngology — Head and Neck Surgery. 2020;163(6):1097-1108. https://doi.org/10.1177/0194599820931455
  25. Bousquet J, Devillier P, Arnavielhe S, Bedbrook A, Alexis-Alexandre G, van Eerd M, Murray R, Canonica GW, Illario M, Menditto E, Passalacqua G, Stellato C, Triggiani M, Carreiro-Martins P, Fonseca J, Morais Almeida M, Nogueira-Silva L, Pereira AM, Todo Bom A, Bosse I, Caimmi D, Demoly P, Fontaine JF, Just J, Onorato GL, Kowalski ML, Kuna P, Samolinski B, Anto JM, Mullol J, Valero A, Tomazic PV, Bergmann KC, Keil T, Klimek L, Mösges R, Shamai S, Zuberbier T, Murphy E, McDowall P, Price D, Ryan D, Sheikh A, Chavannes NH, Fokkens WJ, Kvedariene V, Valiulis A, Bachert C, Hellings PW, Kull I, Melen E, Wickman M, Bindslev-Jensen C, Eller E, Haahtela T, Papadopoulos NG, Annesi-Maesano I, Bewick M, Bosnic-Anticevich S, Cruz AA, De Vries G, Gemicioglu B, Larenas-Linnemann D, Laune D, Mathieu-Dupas E, O’Hehir RE, Pfaar O, Portejoie F, Siroux V, Spranger O, Valovirta E, VandenPlas O, Yorgancioglu A. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study. Allergy. 2018;73(9):1763-1774. https://doi.org/10.1111/all.13406
  26. Bédard A, Basagaña X, Anto JM, Garcia-Aymerich J, Devillier P, Arnavielhe S, Bedbrook A, Onorato GL, Czarlewski W, Murray R, Almeida R, Fonseca J, Costa E, Malva J, Morais-Almeida M, Pereira AM, Todo-Bom A, Menditto E, Stellato C, Ventura MT, Cruz AA, Stelmach R, da Silva J, Larenas-Linnemann D, Fuentes-Pérez JM, Huerta-Villalobos YR, Emuzyte R, Kvedariene V, Valiulis A, Kuna P, Samolinski B, Klimek L, Mösges R, Pfaar O, Shamai S, Annesi-Maesano I, Bosse I, Demoly P, Fontaine JF, Cardona V, Mullol J, Valero A, Roller-Wirnsberger RE, Tomazic PV, Chavannes NH, Fokkens WJ, Reitsma S, Bewick M, Ryan D, Sheikh A, Haahtela T, Toppila-Salmi S, Valovirta E, Makris M, Papadopoulos NG, Prokopakis EP, Psarros F, Cingi C, Gemicioğlu B, Yorgancioglu A, Bosnic-Anticevich S, O’Hehir RE, Bachert C, Hellings PW, Pugin B, Bindslev-Jensen C, Eller E, Kull I, Melén E, Wickman M, De Vries G, van Eerd M, Agache I, Ansotegui IJ, Dykewicz MS, Casale T, Wallace D, Waserman S, Laune D, Bousquet J; MASK study group. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. Journal of Allergy and Clinical Immunology. 2019;144(1):135-143.e6.  https://doi.org/10.1016/j.jaci.2019.01.053
  27. Du K, Qing H, Zheng M, Wang X, Zhang L. Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis. Annals of Allergy, Asthma and Immunology. 2020;125(5):589-596.e3.  https://doi.org/10.1016/j.anai.2020.06.038
  28. Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S, Walter Canonica G, Melén E, Palomares O, Scadding GK, Togias A, Toppila-Salmi S. Allergic rhinitis. Nature Reviews. Disease Primers. 2020;6(1):95.  https://doi.org/10.1038/s41572-020-00227-0
  29. Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R, Canonica GW, Casale T, Chavannes NH, Correia de Sousa J, Cruz AA, Cuello-Garcia CA, Demoly P, Dykewicz M, Etxeandia-Ikobaltzeta I, Florez ID, Fokkens W, Fonseca J, Hellings PW, Klimek L, Kowalski S, Kuna P, Laisaar KT, Larenas-Linnemann DE, Lødrup Carlsen KC, Manning PJ, Meltzer E, Mullol J, Muraro A, O’Hehir R, Ohta K, Panzner P, Papadopoulos N, Park HS, Passalacqua G, Pawankar R, Price D, Riva JJ, Roldán Y, Ryan D, Sadeghirad B, Samolinski B, Schmid-Grendelmeier P, Sheikh A, Togias A, Valero A, Valiulis A, Valovirta E, Ventresca M, Wallace D, Waserman S, Wickman M, Wiercioch W, Yepes-Nuñez JJ, Zhang L, Zhang Y, Zidarn M, Zuberbier T, Schünemann HJ. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines — 2016 revision. Journal of Allergy and Clinical Immunology. 2017;140(4):950-958.  https://doi.org/10.1016/j.jaci.2017.03.050
  30. Wise SK, Damask C, Roland LT, Ebert C, Levy JM, Lin S, Luong A, Rodriguez K, Sedaghat AR, Toskala E, Villwock J, Abdullah B, Akdis C, Alt JA, Ansotegui IJ, Azar A, Baroody F, Benninger MS, Bernstein J, Brook C, Campbell R, Casale T, Chaaban MR, Chew FT, Chambliss J, Cianferoni A, Custovic A, Davis EM, DelGaudio JM, Ellis AK, Flanagan C, Fokkens WJ, Franzese C, Greenhawt M, Gill A, Halderman A, Hohlfeld JM, Incorvaia C, Joe SA, Joshi S, Kuruvilla ME, Kim J, Klein AM, Krouse HJ, Kuan EC, Lang D, Larenas-Linnemann D, Laury AM, Lechner M, Lee SE, Lee VS, Loftus P, Marcus S, Marzouk H, Mattos J, McCoul E, Melen E, Mims JW, Mullol J, Nayak JV, Oppenheimer J, Orlandi RR, Phillips K, Platt M, Ramanathan M Jr, Raymond M, Rhee CS, Reitsma S, Ryan M, Sastre J, Schlosser RJ, Schuman TA, Shaker MS, Sheikh A, Smith KA, Soyka MB, Takashima M, Tang M, Tantilipikorn P, Taw MB, Tversky J, Tyler MA, Veling MC, Wallace D, Wang Y, White A, Zhang L. International consensus statement on allergy and rhinology: Allergic rhinitis — 2023. International Forum of Allergy and Rhinology. 2023;13(4):293-859.  https://doi.org/10.1002/alr.23090
  31. Abdullah B, Abdul Latiff AH, Manuel AM, Mohamed Jamli F, Dalip Singh HS, Ismail IH, Jahendran J, Saniasiaya J, Keen Woo KC, Khoo PC, Singh K, Mohammad N, Mohamad S, Husain S, Mösges R. Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology. Journal of Asthma and Allergy. 2022;15:983-1003. https://doi.org/10.2147/JAA.S374346
  32. Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, Kawauchi H, Suzaki H, Fujieda S, Masuyama K; Japanese Society of Allergology. Japanese guidelines for allergic rhinitis. 2020. Allergology international. 2020;69(3):331-345.  https://doi.org/10.1016/j.alit.2020.04.001
  33. Krishnamoorthy M, Mohd Noor N, Mat Lazim N, Abdullah B. Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis. Drugs. 2020;80(17):1831-1851. https://doi.org/10.1007/s40265-020-01406-9
  34. Ciebiada M, Górska-Ciebiada M, DuBuske LM, Górski P. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Annals of Allergy, Asthma and Immunology. 2006;97(5):664-671.  https://doi.org/10.1016/S1081-1206(10)61098-8
  35. Weinstein SF, Philip G, Hampel FC Jr, Malice MP, Swern AS, Dass SB, Reiss TF. Onset of efficacy of montelukast in seasonal allergic rhinitis. Allergy and Asthma Proceedings. 2005;26(1):41-46. 
  36. Goh BS, Ismail MIM, Husain S. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study. The Journal of Laryngology and Otology. 2014;128(3):242-248. 
  37. Seresirikachorn K, Mullol J, Limitlaohaphan K, Asvapoositkul V, Snidvongs K. Leukotriene receptor antagonist addition to intranasal steroid: systematic review and meta-analysis. Rhinology. 2021;59(1):2-9.  https://doi.org/10.4193/Rhin20.126
  38. Pinar E, Eryigit O, Oncel S, Calli C, Yilmaz O, Yuksel H. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis. Auris, Nasus, Larynx. 2008;35(1):61-66. 
  39. Savlevich EL, Kurbacheva OM, Zurochka AV, Mitrofanova ES, Smolkin YS, Lyubimova EV. The role of leukotriene receptor blockers in the treatment of allergic rhinitis in combination with chronic rhinosinusitis with nasal polyps. Meditsinskij sovet. 2022;8: 111-116. (In Russ.). https://doi.org/10.21518/2079-701X-2022-16-8-111-116
  40. Sancaklı Ö, Belverenli H. Clinical features of patients with allergic rhinitis and evaluation of adenoid hypertrophy as a comorbidity. Journal of Behcet Uz Children’s Hospital. 2019; 9(2):125-130. 
  41. Chang HH, Zhang XY, An L, Dang PH, Luo J, Wang J. Novel Classification System of Adenoids Based on Appearance and Its Relationship with Drug Therapy. International Archives of Allergy and Immunology. 2023;184(7):634-642.  https://doi.org/10.1159/000528445
  42. Vaiman OA. Prospects for the use of antileukotriene drugs in children with pathology of the lymphopharyngeal ring. Rossijskaya otorinolaringologiya. 2009;2:184-189. (In Russ.).
  43. Passali D, Spinosi MC, Crisanti A, Bellussi LM. Mometasone furoate nasal spray: a systematic review. Multidisciplinary Respiratory Medicine. 2016;11:18.  https://doi.org/10.1186/s40248-016-0054-3
  44. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. Journal of Investigational Allergology and Clinical Immunology. 2012;22(1):1-12. 
  45. Kim MK, Lee SY, Park HS, Yoon HJ, Kim SH, Cho YJ, Yoo KH, Lee SK, Kim HK, Park JW, Park HW, Chung JH, Choi BW, Lee BJ, Chang YS, Jo EJ, Lee SY, Cho YS, Jee YK, Lee JM, Jung J, Park CS. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis. Clinical Therapeutics. 2018;40(7):1096-1107.e1.  https://doi.org/10.1016/j.clinthera.2018.04.021
  46. Mahatme MS, Dakhale GN, Tadke K, Hiware SK, Dudhgaonkar SD, Wankhede S. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial. Indian Journal of Pharmacology. 2016;48(6):649-653.  https://doi.org/10.4103/0253-7613.194854
  47. Liu G, Zhou X, Chen J, Liu F. Oral Antihistamines Alone vs in Combination with Leukotriene Receptor Antagonists for Allergic Rhinitis: A Meta-analysis. Otolaryngology — Head and Neck Surgery. 2018;158(3):450-458.  https://doi.org/10.1177/0194599817752624
  48. Wei C. The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: A systematic review and meta-analysis. Biomedicine and Pharmacotherapy. 2016;83:989-997.  https://doi.org/10.1016/j.biopha.2016.08.003
  49. Chitsuthipakorn W, Hoang MP, Kanjanawasee D, Seresirikachorn K, Snidvongs K. Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta-analyses. International Forum of Allergy and Rhinology. 2022;12(12):1480-1502. https://doi.org/10.1002/alr.23015
  50. Ridolo E, Incorvaia C, Pucciarini F, Makri E, Paoletti G, Canonica GW. Current treatment strategies for seasonal allergic rhinitis: where are we heading? Clinical and Molecular Allergy. 2022;20(1):9.  https://doi.org/10.1186/s12948-022-00176-x
  51. Wei Q, Zhou J, Li H, Wang L, Wu Y, Ma A, Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology. 2023;14:1156081. https://doi.org/10.3389/fphar.2023.1156081
  52. Raju K, Elumalai A, Sridhar E. Topic irrational drug combination. International Journal of Experimental Pharmacology. 2013;3(2):52-56. 
  53. Rathod RT, Misra D. FDC of montelukast with levocetirizine: focus on bilayer technology. Journal of the Indian Medical Association. 2009;107(8):562-564. 
  54. Benninger MS, Waters H. Montelukast: Pharmacology, Safety, Tolerability and Efficacy. Clinical Medicine Therapeutics. 2009;1: 1253-1261.
  55. Chattopadhyay S, Majumdar AB, Sengupta A, Biswas D, Pal A, Dastidar N. Does Separate Administration of Montelukast and Levocetirizine Provide Better Results in Perennial Allergic Rhinitis: A Hospital Based Study. Indian Journal of Otolaryngology and Head and Neck Surgery. 2019;71(Suppl 3):1674-1678. https://doi.org/10.1007/s12070-015-0910-z
  56. Polyakova OV, Blinkova EYu, Samokhvalova VV, Stepanenko KV. The role of modern antihistamines in the treatment of allergic diseases. Lekarstvennyj vestnik. 2020;1(77):3-10. (In Russ.).
  57. Kurbacheva OM, Luss LV, Fedenko ES. Multiple allergies: What are we doing wrong? Meditsinskij sovet. 2018;8:104-110. (In Russ.).
  58. Bukstein DA, Lapine TJ. Allergic Rhinitis in Family Practice: The Role of Levocetirizine in Clinical Care. Postgraduate Medicine. 2008;120(2):101-110.  https://doi.org/10.3810/pgm.2008.07.1797
  59. Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clinical Therapeutics. 2009;31(8):1664-1687.
  60. Recto MT, Gabriel MT, Kulthanan K, Tantilipikorn P, Aw DC, Lee TH, Chwen CC, Mutusamy S, Hao NT, Quang VT, Canonica GW. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clinical and Molecular Allergy: CMA. 2017;15:19.  https://doi.org/10.1186/s12948-017-0074-3
  61. Greiner AN, Meltzer EO. Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. Proceedings of the American Thoracic Society. 2011;8(1):121-131.  https://doi.org/10.1513/pats.201004-033RN
  62. Kim S, Ko JW, Kim JR. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets. International Journal of Clinical Pharmacology and Therapeutics 2018;56(9):443-450.  https://doi.org/10.5414/CP203265
  63. Moon SJ, Yu KS, Jung J, Kim YI, Kim MG. Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects. International Journal of Clinical Pharmacology and Therapeutics. 2020;58(6):354-362.  https://doi.org/10.5414/CP203709
  64. Zyryanov SK, Fitilev SB, Shkrebneva II, Vozzhaev AV. Drug interchangeability — clinical efficacy, safety. Nevrologiya, nejropsikhiatriya, psikhosomatika. 2017;S1:4-10. (In Russ.).
  65. Maksimov ML, Ermolaeva AS. Topical issues of drug interchangeability: original bisoprolol or reproduced drugs (generics)? RMZh. 2018;6(1):29-32. (In Russ.).
  66. Ushkalova EA, Zyryanov SK, Butranova OI. Sovremennye aspekty farmakoterapii: original’nye preparaty i generiki. M.: AST 345; 2022. (In Russ.).
  67. White CM. Generic Drugs Not as Safe as FDA Wants You to Believe. Annals of Pharmacotherapy. 2020;54(3):283-286.  https://doi.org/10.1177/1060028019881692
  68. Hsu CW, Lee SY, Yang YH, Wang LJ. Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan. International Journal of Neuropsychopharmacology. 2020;23(10):653-661.  https://doi.org/10.1093/ijnp/pyaa041
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.